As of 2026-03-30, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.06 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 CAD, the upside of BetterLife Pharma Inc is -193.72%.
Based on its market price of 0.07 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 193.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -193.72% |
| P/E | 0.06 - 0.06 | 0.06 | -0.7% |
| DDM - Stable | (0.12) - (0.54) | (0.33) | -606.2% |
| DDM - Multi | (0.75) - (2.66) | (1.17) | -1906.2% |
| Market Cap (mil) | 9.87 |
| Beta | 0.26 |
| Outstanding shares (mil) | 151.90 |
| Enterprise Value (mil) | 10.53 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.59% |
| Cost of Debt | 5.00% |
| WACC | 8.17% |